Founded in 2003, Machaon Diagnostics is a preferred laboratory partner to pharmaceutical firms conducting clinical trials in
the areas of thrombosis, hemostasis, nephology and rare disease. We offer both CAP/CLIA and GLP testing and regulatory-compliant method validation solutions for submission to the FDA and other regulatory bodies. Machaon Diagnostics has emerged as a leadinglaboratory for complement gene sequencing and other testing, due to our rapid turnaround and expedited study capabilities.
American Thrombosis and Hemostasis Network Expertise Partner www.athn.org
The American Thrombosis and Hemostasis Network (ATHN) is a nonprofit dedicated to improving the lives of people affected by bleeding and clotting disorders. We partner with the medical community, government, and industry to provide a technological infrastructure to secure and manage data, support research, measure outcomes, and transform care. Over 38,500 patients have signed up to share their demographic, clinical, and genetic information as part of the ATHNdataset for research. To date, ATHN has launched nine research projects that rely on this valuable data.